Pharma News
Last update 23 Oct 2026

#unloxcyt

1 story tagged "unloxcyt".

Advertise Here
Reach qualified buyers

Boost your visibility among pharma sourcing professionals and potential buyers.

  • Grow your business with qualified leads
  • GDS reports on your ad performance
  • Targeted to this product's audience
  • Direct enquiries from buyers
  • Visibility to pharma professionals
Buy This Ad Space
All news Industry News Regulatory
TOP STORY
Industry News20 Oct 2026

Sun Pharma’s UNLOXCYT gets NCCN Category 2A recommendation for locally advanced skin cancer

The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell carcinoma

Indianpharmapost•20 Oct 2026 •1 min read

Latest news

Showing 1–1 of 1 stories
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.